Clinical Trial Update: A Study Of PF-06747143, As Single Agent Or In Combination With Standard Chemotherapy In Adult Patients With Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

Phase 1 study of PF-06747143 as a single agent or with standard chemotherapy in adult acute myeloid leukemia was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• PF-06747143

Snippet

Sponsor: Pfizer | Conditions: Acute Myeloid Leukemia | Phase 1 | Status: TERMINATED | Results posted: 2019-03-18